Products Signal

Divergent National Court Rulings on SPC Eligibility for Combination Products Signal Possible CJEU Reconsideration

National courts across Europe have reached differing conclusions on whether supporting data in the basic patent specification are necessary to satisfy the CJEU’s test for SPC eligibility of combination pharmaceutical products. While some courts have accepted mechanistic statements without data as sufficient, others ha…